#Johnsonandjohnson

Dr Siddharth Sridhar

sid8998

I feel most companies erred by pursuing protection against symptomatic #COVID19 as the primary efficacy outcome in vaccine trials. The confusing range of percentages across different #vaccines has adversely impacted

Dear Pandemic

DearPandemic

1/ Q: What’s going on with the new #johnsonandjohnson/#janssen vaccine results?A: Some very positive signs for immune responses from newly published Phase 1/2 trial results, & Phase 3 efficacy results

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.